Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-year persistence of yellow fever vaccine protection in adults vaccinated at age 60 years or older
NL-OMON48529Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2019
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of 17D yellow fever vaccine in yellow fever (2 cohorts), sponsored by Amsterdam University Medical Center. Started Nov 2019; status: active, not recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON48529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48529.